bd 1047 has been researched along with Seizures in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baek, IH; Bing, G; Chae, JS; Kim, HC; Kim, WK; Maurice, T; Nabeshima, T; Nah, SY; Shin, EJ; Shin, SW; Yen, TP | 1 |
Bowen, WD; de Costa, BR; Matsumoto, RR; McCracken, KA | 1 |
2 other study(ies) available for bd 1047 and Seizures
Article | Year |
---|---|
Dextromethorphan attenuates trimethyltin-induced neurotoxicity via sigma1 receptor activation in rats.
Topics: Adrenergic alpha-Antagonists; Animals; Avoidance Learning; Behavior, Animal; Dextromethorphan; Ethylenediamines; Immunohistochemistry; Learning Disabilities; Maze Learning; Memory; Nerve Degeneration; Neurotoxicity Syndromes; Piperidines; Radioligand Assay; Rats; Rats, Inbred F344; Receptors, Phencyclidine; Receptors, sigma; Seizures; Sigma-1 Receptor; Trimethyltin Compounds | 2007 |
Two novel sigma receptor ligands, BD1047 and LR172, attenuate cocaine-induced toxicity and locomotor activity.
Topics: Animals; Behavior, Animal; Binding, Competitive; Brain; Cocaine; Ethylenediamines; Guinea Pigs; In Vitro Techniques; Ligands; Male; Mice; Motor Activity; Rats; Rats, Sprague-Dawley; Receptors, sigma; Seizures | 1999 |